GGrantIndex
Sort

21,453 grants matching tuberculosis

Uganda HIV/TB COHRE Training Program

$299,267
Case Western Reserve University · U2R · FY2004 · TW

Novel Mechanisms and Approaches to Treat Neonatal Sepsis

$299,250
Lyle L Moldawer · University Of Florida · R01 · FY2016 · GM

Novel Mechanisms and Approaches to Treat Neonatal Sepsis

$299,250
Lyle L Moldawer · University Of Florida · R01 · FY2015 · GM

Control of DNA Topology

$299,250
Yuk-Ching Tse-Dinh · New York Medical College · R01 · FY2006 · GM

BIOCHEMISTRY AND HEPATIC TOXICITY OF CARBON RADICALS

$299,246
Paul R Ortiz De Montellano · University Of California, San Francisco · R01 · FY2007 · GM

RAPID AFFORDABLE TB DRUG SUSCEPTIBILITY TESTING

$299,229
Howard M. Shapiro · Howard M. Shapiro, Md, P.C. · R43 · FY2008 · AI

Virulence Related Genetic Variation of M. TB Strains

$299,200
University Of Michigan At Ann Arbor · R01 · FY2004 · AI

A new essential protein kinase in Mycobacterium tuberculosis

$299,187
Christoph Grundner · Seattle Biomedical Research Institute · R21 · FY2016 · AI

Infectious Diseases Training program in Bolivia: South-South Training with Peru

$299,166
Robert H Gilman · Johns Hopkins University · D43 · FY2020 · TW

A Second-Generation Patch Test for Tuberculosis

$299,160
Carol A. Nacy · Sequella, Inc. · U01 · FY2006 · AI

Virulence Related Genetic Variation of M. TB Strains

$299,087
University Of Michigan At Ann Arbor · R01 · FY2005 · AI

Northeast Biodefense Center

$299,076
W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2014 · AI

BCG + hsp, a New Tuberculosis Vaccine

$299,045
Sequella, Inc. · R43 · FY2003 · AI

TB and Innate Immune Regulation of Lung Macrophages

$299,000
Ohio State University · R21 · FY2004 · AI

Design of antituberculosis agents that target siderophore biosynthesis

$299,000
Courtney C Aldrich · University Of Minnesota · R01 · FY2006 · AI

Building the Next Generation of Researchers in TB/HIV Diagnostics in Mali (B-NextGen)

$298,963
Robert L. Murphy · Northwestern University At Chicago · D43 · FY2024 · TW

Development of nitroreductase-activated inhibitors to treat mycobacterial infections

$298,829
John James Vrbanac · Tarn Biosciences, Inc. · R41 · FY2025 · AI

Heterogeneity of T-cells in M. tuberculosis Infection

$298,809
W. Henry Henry Boom · Case Western Reserve University · R01 · FY2006 · AI

Bacterial N-Acetyltransferases: Resistance to Regulation

$298,805
John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2018 · AI

Natural product-inspired antibacterials with unique ribosomal binding

$298,770
Charles Testa · Curza Inc · R43 · FY2017 · AI

CAfGEN Administrative Centre

$298,761
Mogomotsi Sandy Matshaba · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2021 · AI

Molecular and Cell Biology in Environmental Medicine

$298,703
New York University School Of Medicine · T32 · FY2005 · ES

Genetically Defined Attenuated Living Vaccine for Francisella

$298,617
Fred L Heffron · Virogenomics, Inc. · R41 · FY2008 · AI

Conformational dynamics and allosteric regulation during stress-responsive metallocofactor assembly

$298,607
Patrick Frantom · University Of Alabama In Tuscaloosa · R01 · FY2022 · GM

FEND-TB

$298,587
Jerrold J. Ellner · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI